Freida Toler
Family · Amarillo, TXNPI 1922306240
Payments from drug & device makers
Across 341 payments — averaging $26.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$2K
- Amgen$1K
- AbbVie$755
- AstraZeneca$627
- Boehringer Ingelheim$600
- Lilly USA, LLC$592
- plus $4K from 30 others
What the payments were for
- Food & beverage$9,165100%
- Education$220%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 63 | $1,709 |
| Amgen(2 entities) | 26 | $1,049 |
| AbbVie | 25 | $755 |
| AstraZeneca(2 entities) | 12 | $627 |
| Boehringer Ingelheim | 31 | $600 |
| Lilly USA, LLC | 38 | $592 |
| Bayer | 15 | $374 |
| Sanofi-aventis U.S. LLC | 15 | $317 |
| Abbott | 16 | $305 |
| Insulet Corporation | 8 | $290 |
| GSK | 7 | $284 |
| Radius Health, Inc. | 13 | $270 |
| Astellas Pharma US Inc | 2 | $250 |
| Dexcom, Inc. | 13 | $215 |
| Medtronic | 2 | $179 |
| Xeris Pharmaceuticals, Inc. | 10 | $169 |
| Phathom Pharmaceuticals, Inc. | 3 | $154 |
| Corcept Therapeutics | 5 | $135 |
| Optinose US, Inc. | 2 | $127 |
| Tandem Diabetes Care, Inc. | 7 | $105 |
| Mannkind Corporation | 6 | $103 |
| Neurocrine Biosciences, Inc. | 1 | $96 |
| Recordati_rare_diseases_inc. | 5 | $82 |
| Biohaven Pharmaceuticals, Inc. | 1 | $68 |
| Madrigal Pharmaceuticals | 2 | $51 |
| Amarin Pharma, Inc. | 2 | $39 |
| Sequel Med Tech, LLC | 1 | $36 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $34 |
| EUSA Pharma (US) LLC | 2 | $33 |
| Soleno Therapeutics, Inc. | 1 | $30 |
| Acella Pharmaceuticals, LLC | 1 | $22 |
| IBSA Pharma Inc. | 1 | $22 |
| Seqirus USA Inc | 1 | $20 |
| Johnson & Johnson | 1 | $17 |
| Sanofi Pasteur Inc. | 1 | $15 |
| Pfizer | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,187 in reported general payments places this provider in the 95th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 127 | $189,019 |
| MounjaroTirzepatide | 63 | $90,073 |
| Tresiba Flextouch U-200Insulin Degludec | 49 | $80,984 |
| JardianceEmpagliflozin | 52 | $63,097 |
| Tresiba Flextouch U-100Insulin Degludec | 70 | $46,282 |
| TrulicityDulaglutide | 27 | $42,617 |
| FarxigaDapagliflozin Propanediol | 28 | $37,530 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 52 | $34,179 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 11 | $27,044 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 15 | $18,958 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 77 | $13,351 |
| HumalogInsulin Lispro | 27 | $10,952 |
| Humalog Kwikpen U-100Insulin Lispro | 22 | $10,537 |
| ZenpepLipase/Protease/Amylase | 11 | $10,455 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 11 | $9,482 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Novolog | $1,709 | $193,814140 claims |
| Lilly USA, LLCMounjaro, Trulicity, Humalog | $592 | $143,642117 claims |
| Boehringer IngelheimJardiance | $600 | $63,09752 claims |
| AstraZenecaFarxiga | $627 | $37,53028 claims |
| Sanofi-aventis U.S. LLCLantus | $317 | $5,50822 claims |
| AbbVieSynthroid | $755 | $1,93237 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 15,456 family providers in Texas.
Other family in Amarillo
- Kyla BeedyAmarillo$54K
- Tiffany RandleAmarillo$50K
- Cory PickettAmarillo$34K
- Lashonda CraneHouston$3.4M
- David WeirDallas$959K
- Luba YammineHouston$479K
- Robin BeachHouston$428K
- Nirupama JeromeAustin$418K
- April LopezMcAllen$417K
- Linda MercadoHouston$211K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.